Despite the changing landscape of treatment of coronary artery disease (CAD), coronary artery bypass grafting (CABG) remains a safe and effective option for treatment of multivessel obstructive CAD. Since its introduction in mid 1960s, CABG has evolved tremendously making it the only evidence-backed standard of care for treatment of CAD with well-established symptomatic and prognostic benefits. This series is dedicated to providing an overview of CABG covering the various surgical techniques in particular and the evolution of CABG in general. Articles are contributed by world experts and opinion leaders and expected to provide an insight to the readers into the past, present and future of CABG.
The series “Coronary Artery Bypass Grafting”was commissioned by the editorial office, AME Medical Journal without any sponsorship or funding. Shahzad G. Raja served as the unpaid Guest Editor for the series.